From: Proteomic profiling of HBV infected liver biopsies with different fibrotic stages
Statistics (N = 47) | ||
---|---|---|
Age (mean ± sem) | 40.98 ± 2.063 (19–66) | |
Sex | Male | 30 (63.8%) |
Female | 17 (36.2%) | |
F-score | 1 | 7 |
2 | 20 | |
3 | 12 | |
4 | 3 | |
5 | 2 | |
6 | 3 | |
HAI (mean ± sem) | 5.36 ± 0.366 (2–11) | |
logHBVDNA (mean ± sem) | 6.04 ± 0.263 (1.77–8.94) | |
AST (mean ± sem) | 54.59 ± 7.697 (16–309) | |
ALT (mean ± sem) | 88.89 ± 14.569 (14–441) | |
PLT (x103) (mean ± sem) | 218 ± 8.4 (119–370) | |
PT (mean ± sem) | 13.23 ± 0.13 (11.4–16.1) | |
INR (mean ± sem) | 1.03 ± 0.0178 (0.85–1.39) | |
HDL (mean ± sem) | 46.65 ± 2.29 (27–72) | |
LDL (mean ± sem) | 116 ± 5.27 (60–167) | |
Triglyceride (mean ± sem) | 105.17 ± 9.59 (36–359) | |
Glucose (mean ± sem) | 103.02 ± 6.1 (76–295) | |
Waist (cm) (mean ± sem) | 92.48 ± 2.1 (62–120) | |
BMI (mean ± sem) | 27 ± 0.7 (19–38) | |
HBeAg | Positive | 11 (23.4%) |
Negative | 36 (76.6%) |